GAMBARAN KOMORBIDITAS PASIEN RAWAT INAP COVID-19 DI RSUD SOEDARSO TAHUN 2021

Authors

  • Raisah Hulaimah Nashruddin Program Studi Sarjana Kedokteran, Fakultas Kedokteran, Universitas Tanjungpura
  • Abror Irsan Departemen Kesehatan Masyarakat, Fakultas Kedokteran, Universitas Tanjungpura
  • Mitra Handini Departemen Fisiologi, Fakultas Kedokteran, Universitas Tanjungpura

DOI:

https://doi.org/10.31004/prepotif.v9i2.47510

Keywords:

Komorbiditas, tingkat keparahan COVID-19

Abstract

Komorbiditas menjadi faktor risiko untuk terjadinya perburukan gejala pada pasien COVID-19. Pasien dengan jumlah komorbiditas yang lebih banyak berkorelasi dengan hasil klinis yang lebih buruk. Terdapat beberapa komorbiditas yang menjadi risiko keparahan pada pasien COVID-19, bahkan bisa menyebabkan kematian. Penelitian ini merupakan studi deskriptif retrospektif dengan pendekatan potong lintang. Data diperoleh dari rekam medis 200 pasien COVID-19 yang dirawat di RSUD Soedarso, dan dianalisis secara kuantitatif dan kualitatif. Hasil analisis menunjukkan bahwa sebagian besar responden berjenis kelamin laki-laki (53%) berusia 37-66 tahun (73%), memiliki komorbiditas lebih dari satu (55,5%). Responden dengan komorbiditas lebih dari satu pada tingkat keparahan ringan berjumlah 0,5%, keparahan sedang berjumlah 36,5% dan keparahan berat berjumlah 18,5%. Komorbiditas terbanyak pada responden adalah penyakit hipertensi (46,5%), diabetes melitus tipe 2 (38,5%) dan penyakit kardiovaskular (21%). Sebagian besar responden memiliki komorbiditas lebih dari 1 dengan komorbiditas terbanyak adalah hipertensi, diabetes melitus tipe 2 dan penyakit kardiovaskular.

References

Ahmad, A., Ishtiaq, S. M., Khan, J. A., Aslam, R., Ali, S., & Arshad, M. I. (2021). COVID-19 and comorbidities of hepatic diseases in a global perspective. World Journal of Gastroenterology, 27(13), 1296–1310. https://doi.org/10.3748/WJG.V27.I13.1296

Akhtar, H., Khalid, S., ur Rahman, F., Umar, M., Ali, S., Afridi, M., Hassan, F., Khader, Y. S., Akhtar, N., Khan, M. M., & Ikram, A. (2021). Presenting Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in Pakistan: Retrospective Observational Study. JMIR Public Health Surveill 2021;7(12):E32203 Https://Publichealth.Jmir.Org/2021/12/E32203, 7(12), e32203. https://doi.org/10.2196/32203

Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020). Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA, 323(16), 1612–1614. https://doi.org/10.1001/JAMA.2020.4326

Arroja, M. M. C., Reid, E., & McCabe, C. (2016). Therapeutic potential of the renin angiotensin system in ischaemic stroke. Experimental & Translational Stroke Medicine, 8(1). https://doi.org/10.1186/S13231-016-0022-1

Bonanad, C., García-Blas, S., Tarazona-Santabalbina, F., Sanchis, J., Bertomeu-González, V., Fácila, L., Ariza, A., Núñez, J., & Cordero, A. (2020). The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects. Journal of the American Medical Directors Association, 21(7), 915. https://doi.org/10.1016/J.JAMDA.2020.05.045

Brufsky, A. (2020). Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic. Journal of Medical Virology, 92(7), 770. https://doi.org/10.1002/JMV.25887

Bwire, G. M. (2020). Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women? SN Comprehensive Clinical Medicine, 2(7), 874–876. https://doi.org/10.1007/S42399-020-00341-W

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England), 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7

Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., Skoff, T., & Ussery, E. (2020). Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(13), 382–386. https://doi.org/10.15585/MMWR.MM6913E2

Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T., Harding, C. V., Kwon, D. H., Singh, T., Tilton, J. C., Tsai, E. J., Tucker, N. R., Barnard, J., & Loscalzo, J. (2021). COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circulation Research, 128(8), 1214–1236. https://doi.org/10.1161/CIRCRESAHA.121.317997

Coronavirus disease (COVID-19). (n.d.). Retrieved March 26, 2022, from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19

Corrao, S., Pinelli, K., Vacca, M., Raspanti, M., & Argano, C. (2021). Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Frontiers in Endocrinology, 12. https://doi.org/10.3389/FENDO.2021.609470

Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., … Cai, H. (2020). Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discovery, 10(6), 783. https://doi.org/10.1158/2159-8290.CD-20-0422

Delorey, T. M., Ziegler, C. G. K., Heimberg, G., Normand, R., Yang, Y., Segerstolpe, Å., Abbondanza, D., Fleming, S. J., Subramanian, A., Montoro, D. T., Jagadeesh, K. A., Dey, K. K., Sen, P., Slyper, M., Pita-Juárez, Y. H., Phillips, D., Biermann, J., Bloom-Ackermann, Z., Barkas, N., … Regev, A. (2021). COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature, 595(7865), 107. https://doi.org/10.1038/S41586-021-03570-8

Djaharuddin, I., Munawwarah, S., Nurulita, A., Ilyas, M., Tabri, N. A., & Lihawa, N. (2021). Comorbidities and mortality in COVID-19 patients. Gaceta Sanitaria, 35, S530. https://doi.org/10.1016/J.GACETA.2021.10.085

Farshidfar, F., Koleini, N., & Ardehali, H. (2021). Cardiovascular complications of COVID-19. JCI Insight, 6(13). https://doi.org/10.1172/JCI.INSIGHT.148980

Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., Penzar, D., Perlman, S., Poon, L. L. M., Samborskiy, D. V., Sidorov, I. A., Sola, I., & Ziebuhr, J. (2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology 2020 5:4, 5(4), 536–544. https://doi.org/10.1038/s41564-020-0695-z

Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., Iotti, G., Latronico, N., Lorini, L., Merler, S., Natalini, G., Piatti, A., Ranieri, M. V., Scandroglio, A. M., Storti, E., … Zoia, E. (2020). Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16), 1574–1581. https://doi.org/10.1001/JAMA.2020.5394

Guan, W., Liang, W., Zhao, Y., Liang, H., Chen, Z., Li, Y., Liu, X., Chen, R., Tang, C., Wang, T., Ou, C., Li, L., Chen, P., Sang, L., Wang, W., Li, J., Li, C., Ou, L., Cheng, B., … He, J. (2020a). Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. The European Respiratory Journal, 55(5), 640. https://doi.org/10.1183/13993003.00547-2020

Guan, W., Liang, W., Zhao, Y., Liang, H., Chen, Z., Li, Y., Liu, X., Chen, R., Tang, C., Wang, T., Ou, C., Li, L., Chen, P., Sang, L., Wang, W., Li, J., Li, C., Ou, L., Cheng, B., … He, J. (2020b). Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. European Respiratory Journal, 74(10), 640. https://doi.org/10.1183/13993003.00547-2020

Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S., & Hu, D. (2020). Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes/Metabolism Research and Reviews, 36(7). https://doi.org/10.1002/DMRR.3319

Hu, X., Michael De Silva, T., Chen, J., & Faraci, F. M. (2017). Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke. Circulation Research, 120(3), 449–471. https://doi.org/10.1161/CIRCRESAHA.116.308427

Iacobellis, G. (2020). COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Research and Clinical Practice, 162, 108125. https://doi.org/10.1016/J.DIABRES.2020.108125

Jacob, L., Koyanagi, A., Smith, L., Haro, J. M., Rohe, A. M., & Kostev, K. (2021). Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021. International Journal of Infectious Diseases, 111, 37–42. https://doi.org/10.1016/j.ijid.2021.08.010

Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses, 12(4). https://doi.org/10.3390/V12040372

Kamyshnyi, A., Krynytska, I., Matskevych, V., Marushchak, M., & Lushchak, O. (2020). Arterial hypertension as a risk comorbidity associated with covid-19 pathology. International Journal of Hypertension, 2020. https://doi.org/10.1155/2020/8019360

Kang, D. H., Weaver, M. T., Park, N. J., Smith, B., McArdle, T., & Carpenter, J. (2009). Significant Impairment in Immune Recovery Following Cancer Treatment. Nursing Research, 58(2), 105. https://doi.org/10.1097/NNR.0B013E31818FCECD

Karyono, D. R., & Wicaksana, A. L. (2020). Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of Community Empowerment for Health, 3(2), 77–84. https://doi.org/10.22146/JCOEMPH.57325

Kaushik, P., Kaushik, M., Parveen, S., Tabassum, H., & Parvez, S. (2020). Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic. Molecular Neurobiology, 57(12), 4921. https://doi.org/10.1007/S12035-020-02072-4

Kementerian Kesehatan Republik Indonesia. (2020). Pedoman pencegahan dan pengendalian coronavirus disease (COVID-19). Germas, 0–115.

Khedr, E. M., Abdelrahman, A. A., Desoky, T., Zaki, A. F., & Gamea, A. (2020). Post-stroke depression: frequency, risk factors, and impact on quality of life among 103 stroke patients—hospital-based study. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 56(1), 1–8. https://doi.org/10.1186/S41983-020-00199-8/TABLES/5

Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C. Y., Desai, A., de Lima Lopes, G., Grivas, P., Painter, C. A., Peters, S., Thompson, M. A., Bakouny, Z., Batist, G., Bekaii-Saab, T., Bilen, M. A., Bouganim, N., … West, J. (2020). Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet (London, England), 395(10241), 1907. https://doi.org/10.1016/S0140-6736(20)31187-9

Lee, A. C., Li, W. T., Apostol, L., Ma, J., Taub, P. R., Chang, E. Y., Rajasekaran, M., & Ongkeko, W. M. (2021). Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis. Computational and Structural Biotechnology Journal, 19, 3755. https://doi.org/10.1016/J.CSBJ.2021.06.038

Li, B., Yang, J., Zhao, F., Zhi, L., Wang, X., Liu, L., Bi, Z., & Zhao, Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology, 109(5), 531. https://doi.org/10.1007/S00392-020-01626-9

Liang, W. H., Guan, W. J., Li, C. C., Li, Y. M., Liang, H. R., Zhao, Y., Liu, X., Sang, L., Sang, L., Chen, R. C., Tang, C. L., Wang, T., Wang, W., He, Q. H., Chen, Z. S., Wong, S. S., Zanin, M., Liu, J., Xu, X., … He, J. X. (2020). Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. The European Respiratory Journal, 55(6). https://doi.org/10.1183/13993003.00562-2020

Meng, Y., Wu, P., Lu, W., Liu, K., Ma, K., Huang, L., Cai, J., Zhang, H., Qin, Y., Sun, H., Ding, W., Gui, L., & Wu, P. (2020). Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathogens, 16(4). https://doi.org/10.1371/JOURNAL.PPAT.1008520

Mentri Kesehatan Republik Indonesia. (2020). Penetapan rumah sakit rujukan penanggulangan penyakit infeksi emerging tertentu.

Mona, N. (2020). Konsep Isolasi Dalam Jaringan Sosial Untuk Meminimalisasi Efek Contagious (Kasus Penyebaran Virus Corona Di Indonesia). Jurnal Sosial Humaniora Terapan, 2(2), 117–125. https://doi.org/10.7454/jsht.v2i2.86

Morra, M. E., Van Thanh, L., Kamel, M. G., Ghazy, A. A., Altibi, A. M. A., Dat, L. M., Thy, T. N. X., Vuong, N. L., Mostafa, M. R., Ahmed, S. I., Elabd, S. S., Fathima, S., Le Huy Vu, T., Omrani, A. S., Memish, Z. A., Hirayama, K., & Huy, N. T. (2018). Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis. Reviews in Medical Virology, 28(3). https://doi.org/10.1002/RMV.1977

Nagase, H., Nishimura, Y., Matsumoto, H., Sugimoto, N., Iwanaga, T., Sano, A., Konno, S., Hizawa, N., Asano, K., Horiguchi, T., & Yokoyama, A. (2021). The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society. Respiratory Investigation, 59(5), 679–682. https://doi.org/10.1016/J.RESINV.2021.06.008

Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., Ahluwalia, N., Bikdeli, B., Dietz, D., Der-Nigoghossian, C., Liyanage-Don, N., Rosner, G. F., Bernstein, E. J., Mohan, S., Beckley, A. A., … Wan, E. Y. (2021). Post-acute COVID-19 syndrome. Nature Medicine 2021 27:4, 27(4), 601–615. https://doi.org/10.1038/s41591-021-01283-z

New York State Statewide COVID-19 Hospitalizations and Beds | State of New York. (n.d.). Retrieved October 6, 2022, from https://health.data.ny.gov/Health/New-York-State-Statewide-COVID-19-Hospitalizations/jw46-jpb7/data

Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews. Cardiology, 17(9), 543–558. https://doi.org/10.1038/S41569-020-0413-9

Papa, A., Covino, M., Pizzolante, F., Miele, L., Lopetuso, L. R., Bove, V., Iorio, R., Simeoni, B., Vetrone, L. M., Tricoli, L., Mignini, I., Schepis, T., D’Alessandro, A., Coppola, G., Nicoletti, T., Visconti, E., & Rapaccini, G. (2020). Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19. European Review for Medical and Pharmacological Sciences, 24(13), 7506–7511. https://doi.org/10.26355/EURREV_202007_21923

Peña-Silva, R. A., Chu, Y., Miller, J. D., Mitchell, I. J., Penninger, J. M., Faraci, F. M., & Heistad, D. D. (2012). IMPACT OF ACE2 DEFICIENCY AND OXIDATIVE STRESS ON CEREBROVASCULAR FUNCTION WITH AGING. Stroke; a Journal of Cerebral Circulation, 43(12), 3358. https://doi.org/10.1161/STROKEAHA.112.667063

Rogado, J., Pangua, C., Serrano-Montero, G., Obispo, B., Marino, A. M., Pérez-Pérez, M., López-Alfonso, A., Gullón, P., & Lara, M. Á. (2020). Covid-19 and lung cancer: A greater fatality rate? Lung Cancer (Amsterdam, Netherlands), 146, 19. https://doi.org/10.1016/J.LUNGCAN.2020.05.034

Sandoval, M., Nguyen, D. T., Vahidy, F. S., & Graviss, E. A. (2021). Risk factors for severity of COVID-19 in hospital patients age 18–29 years. PLOS ONE, 16(7), e0255544. https://doi.org/10.1371/JOURNAL.PONE.0255544

Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020). Comorbidity and its Impact on Patients with COVID-19. Sn Comprehensive Clinical Medicine, 2(8), 1069. https://doi.org/10.1007/S42399-020-00363-4

Singh, A. K., Gupta, R., & Misra, A. (2020). Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes & Metabolic Syndrome, 14(4), 283. https://doi.org/10.1016/J.DSX.2020.03.016

Singh, J., Malik, P., Patel, N., Pothuru, S., Israni, A., Chakinala, R. C., Hussain, M. R., Chidharla, A., Patel, H., Patel, S. K., Rabbani, R., Patel, U., Chugh, S., & Kichloo, A. (2022). Kidney disease and COVID-19 disease severity—systematic review and meta-analysis. Clinical and Experimental Medicine, 22(1), 125–135. https://doi.org/10.1007/S10238-021-00715-X/FIGURES/4

Smorenberg, A., Peters, E. J., van Daele, P. LA, Nossent, E. J., & Muller, M. (2021). How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. European Journal of Internal Medicine, 83, 1–5. https://doi.org/10.1016/J.EJIM.2020.11.024

Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76(February), 71–76. https://doi.org/10.1016/j.ijsu.2020.02.034

Song, W. C., & FitzGerald, G. A. (2020). COVID-19, microangiopathy, hemostatic activation, and complement. The Journal of Clinical Investigation, 130(8), 3950–3953. https://doi.org/10.1172/JCI140183

Su, S., Chen, R., Zhang, S., Shu, H., & Luo, J. (2022). Immune system changes in those with hypertension when infected with SARS-CoV-2. Cellular Immunology, 378, 104562. https://doi.org/10.1016/J.CELLIMM.2022.104562

Turner, A. J., Hiscox, J. A., & Hooper, N. M. (2004). ACE2: from vasopeptidase to SARS virus receptor. Trends in Pharmacological Sciences, 25(6), 291. https://doi.org/10.1016/J.TIPS.2004.04.001

Úri, K., Fagyas, M., Kertész, A., Borbély, A., Jenei, C., Bene, O., Csanádi, Z., Paulus, W. J., Édes, I., Papp, Z., Tóth, A., & Lizanecz, E. (2016). Circulating ACE2 activity correlates with cardiovascular disease development. Journal of the Renin-Angiotensin-Aldosterone System: JRAAS, 17(4). https://doi.org/10.1177/1470320316668435

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet (London, England), 395(10234), 1417–1418. https://doi.org/10.1016/S0140-6736(20)30937-5

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology, 94(7). https://doi.org/10.1128/JVI.00127-20

Wang, H., Tang, X., Fan, H., Luo, Y., Song, Y., Xu, Y., & Chen, Y. (2020). Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients. Aging (Albany NY), 12(11), 10022. https://doi.org/10.18632/AGING.103335

Wang, H. Y., Li, X. L., Yan, Z. R., Sun, X. P., Han, J., & Zhang, B. W. (2020). Potential neurological symptoms of COVID-19. Therapeutic Advances in Neurological Disorders, 13. https://doi.org/10.1177/1756286420917830

Wang, T., Du, Z., Zhu, F., Cao, Z., An, Y., Gao, Y., & Jiang, B. (2020). Comorbidities and multi-organ injuries in the treatment of COVID-19. The Lancet, 395(10228), e52. https://doi.org/10.1016/S0140-6736(20)30558-4/ATTACHMENT/543FA63E-F5A5-4300-BC71-D327DD148DB8/MMC1.PDF

Wichmann, D., Sperhake, J. P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., Burdelski, C., de Heer, G., Nierhaus, A., Frings, D., Pfefferle, S., Becker, H., Bredereke-Wiedling, H., de Weerth, A., Paschen, H. R., … Kluge, S. (2020). Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Annals of Internal Medicine, 173(4), 268–277. https://doi.org/10.7326/M20-2003

Wisnu, K., Karya, S., Made Suwidnya, I., & Surya Wijaya, B. (2021). Hubungan penyakit komorbiditas terhadap derajat klinis COVID-19. Intisari Sains Medis, 12(2), 708–717. https://doi.org/10.15562/ISM.V12I2.1143

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., … Song, Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 1. https://doi.org/10.1001/JAMAINTERNMED.2020.0994

Wu, M. Y., Li, C. J., Yiang, G. T., Cheng, Y. L., Tsai, A. P. Y., Hou, Y. T., Ho, Y. C., Hou, M. F., & Chu, P. Y. (2018). Molecular Regulation of Bone Metastasis Pathogenesis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 46(4), 1423–1438. https://doi.org/10.1159/000489184

Wu, Z., & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 323(13), 1239–1242. https://doi.org/10.1001/JAMA.2020.2648

Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nature Medicine 2022 28:3, 28(3), 583–590. https://doi.org/10.1038/s41591-022-01689-3

Yang, J. K., Feng, Y., Yuan, M. Y., Yuan, S. Y., Fu, H. J., Wu, B. Y., Sun, G. Z., Yang, G. R., Zhang, X. L., Wang, L., Xu, X., Xu, X. P., & Chan, J. C. N. (2006). Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic Medicine : A Journal of the British Diabetic Association, 23(6), 623–628. https://doi.org/10.1111/J.1464-5491.2006.01861.X

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases, 94, 91–95. https://doi.org/10.1016/J.IJID.2020.03.017

Zhang, L., Richards, A., Inmaculada Barrasa, M., Hughes, S. H., Young, R. A., & Jaenisch, R. (2021). Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proceedings of the National Academy of Sciences of the United States of America, 118(21), e2105968118. https://doi.org/10.1073/PNAS.2105968118/SUPPL_FILE/PNAS.2105968118.SD04.XLSX

Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R., Jia, P., Guan, H. Q., Peng, L., Chen, Y., Peng, P., Zhang, P., Chu, Q., Shen, Q., Wang, Y., Xu, S. Y., Zhao, J. P., & Zhou, M. (2020). Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of Oncology, 31(7), 894. https://doi.org/10.1016/J.ANNONC.2020.03.296

Zhang, T., Zhong, S., & Cao, W. (2020). COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit? Prehospital and Disaster Medicine, 35(6), 1. https://doi.org/10.1017/S1049023X20001090

Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020). Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 202(5), 756–759. https://doi.org/10.1164/RCCM.202001-0179LE/SUPPL_FILE/DISCLOSURES.PDF

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMOA2001017

Downloads

Published

2025-08-28

How to Cite

Nashruddin, R. H., Irsan, A., & Handini, M. (2025). GAMBARAN KOMORBIDITAS PASIEN RAWAT INAP COVID-19 DI RSUD SOEDARSO TAHUN 2021. PREPOTIF : JURNAL KESEHATAN MASYARAKAT, 9(2), 6135–6149. https://doi.org/10.31004/prepotif.v9i2.47510